Vir Biotechnology Inc. News
GlaxoSmithKline, Vir Say U.S. to Buy 600,000 More Covid Doses
The agreement includes the option for the U.S. to buy additional doses in the second quarter, the companies say.
Tech Stocks Surge, Dow Roars; Fauci Says Omicron Variant 'Almost Certainly' Less Severe Than Delta
Wall Street looks set to recoup all -- and more -- of last week's Omicron-linked declines as investors look past risks tied to the new variant, which may be milder and less virulent that first anticipated.
GlaxoSmithKline, Vir Biotechnology Say COVID Therapy Effective Against Omicron Variant
GlaxoSmithKline and its U.S. partner, Vir Biotechnology, said Tuesday that their COVID antibody is effective against all mutations of the new Omicron variant.
Intel, Samsung, Omicron, Tesla and Surging Stock Markets - 5 Things You Must Know
Stocks futures extend gains as Omicron risks fade, Glaxo and Vir Bio say COVID therapy effective against variant; Intel plans potential $50 billion Mobileye IPO; Samsung merges phone and electronics division in major restructuring and Elon Musk says Biden's EV incentives shouldn't pass congress.
Cramer's Mad Money Recap 12/2: Mastercard, Affirm, Boeing
Jim Cramer says market sentiment may be fickle, but it also can be a powerful driver of buying opportunities for investors who do their homework.
Breaking News
FTX Reportedly Close to Buying BlockFi
An acquisition could take several months to close, and the price could shift between now and Friday.
Morningstar's Five Coping Mechanisms for Bear Market
The S&P 500 is in a bear market, having lost 20% so far this year. So what’s an investor to do?
Economist Roubini: Why Stocks Poised for 50% Wipeout
The stock market is off to its worst start to a year since 1962, with the S&P 500 dropping 21% in the first half of 2022.
Who Is the Mystery Crypto Queen on the Run After an Alleged Scam?
The FBI is offering anyone who helps arrest OneCoin co-founder Dr. Ruja Ignatova $100,000.